drugset / Trial / NCT03424239
Pilot Study for Zoledronic Acid to Prevent Bone Loss After Bariatric Surgery
NaSingle-groupOpen-labelPrevention
Summary
This study evaluates whether zoledronic acid can prevent the high bone turnover that occurs after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.
Timeline
- Start
- 2018-08-01
- Primary completion
- 2020-01-01
- Completion
- 2020-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zoledronic acid | Other / unclassified | 5 mg | Intravenous |
Indications
No indication recorded.